Table 4.
Variables | P | OR | 95% CI |
---|---|---|---|
Age | 0.153 | 1.046 | 0.983–1.112 |
Male | 0.988 | 0.993 | 0.360–2.739 |
Hypertension | 0.031 | 0.301 | 0.101–0.896 |
Diabetes mellitusb | 0.403 | 0.521 | 0.113–2.405 |
Hyperlipidemiac | 0.350 | 0.371 | 0.047–2.964 |
Previous symptomatic ICH | 0.041 | 2.958 | 1.043–8.387 |
Previous antiplatelet used | 0.965 | 1.030 | 0.276–3.843 |
Previous anticoagulant usee | 0.112 | 9.812 | 0.585–164.479 |
NIHSS scoref | 0.202 | 1.032 | 0.983–1.083 |
ICH volume | 0.193 | 1.010 | 0.995–1.026 |
cSAH presence | 0.005 | 6.290 | 1.740–22.741 |
Adjacent cSAH | 0.002 | 6.152 | 1.916–19.752 |
Remote cSAH | 0.755 | 0.716 | 0.088–5.840 |
Intraventricular hemorrhage presence | 0.055 | 2.711 | 0.980–7.497 |
18 patients were excluded because of missing data on ICH recurrence within 90 days.
5 patients with missing data.
24 patients with missing data.
11 patients with missing data.
4 patients with missing data.
22 patients with missing data.
cSAH, convexity subarachnoid hemorrhage; ICH, intracerebral hemorrhage.